GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Getinge AB (OTCPK:GNGBF) » Definitions » Cyclically Adjusted PB Ratio

Getinge AB (Getinge AB) Cyclically Adjusted PB Ratio : 2.32 (As of Jun. 18, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Getinge AB Cyclically Adjusted PB Ratio?

As of today (2024-06-18), Getinge AB's current share price is $21.17. Getinge AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $9.13. Getinge AB's Cyclically Adjusted PB Ratio for today is 2.32.

The historical rank and industry rank for Getinge AB's Cyclically Adjusted PB Ratio or its related term are showing as below:

GNGBF' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.14   Med: 2.45   Max: 5.5
Current: 1.82

During the past years, Getinge AB's highest Cyclically Adjusted PB Ratio was 5.50. The lowest was 1.14. And the median was 2.45.

GNGBF's Cyclically Adjusted PB Ratio is ranked better than
53.46% of 477 companies
in the Medical Devices & Instruments industry
Industry Median: 2.02 vs GNGBF: 1.82

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Getinge AB's adjusted book value per share data for the three months ended in Mar. 2024 was $11.410. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $9.13 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Getinge AB Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Getinge AB's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Getinge AB Cyclically Adjusted PB Ratio Chart

Getinge AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.48 2.63 5.04 2.36 2.26

Getinge AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.71 1.97 1.98 2.26 2.14

Competitive Comparison of Getinge AB's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Getinge AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Getinge AB's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Getinge AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Getinge AB's Cyclically Adjusted PB Ratio falls into.



Getinge AB Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Getinge AB's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=21.17/9.13
=2.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Getinge AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Getinge AB's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=11.41/132.2054*132.2054
=11.410

Current CPI (Mar. 2024) = 132.2054.

Getinge AB Quarterly Data

Book Value per Share CPI Adj_Book
201406 9.618 100.432 12.661
201409 9.298 100.161 12.273
201412 9.511 100.225 12.546
201503 8.438 99.950 11.161
201506 8.842 99.995 11.690
201509 8.750 100.228 11.542
201512 8.944 100.276 11.792
201603 8.881 100.751 11.654
201606 8.855 101.019 11.589
201609 8.746 101.138 11.433
201612 8.812 102.022 11.419
201703 8.982 102.022 11.639
201706 8.953 102.752 11.519
201709 10.696 103.279 13.692
201712 8.480 103.793 10.801
201803 8.750 103.962 11.127
201806 8.622 104.875 10.869
201809 7.591 105.679 9.496
201812 7.807 105.912 9.745
201903 7.800 105.886 9.739
201906 7.622 106.742 9.440
201909 7.712 107.214 9.510
201912 7.978 107.766 9.787
202003 8.303 106.563 10.301
202006 8.199 107.498 10.083
202009 8.924 107.635 10.961
202012 9.230 108.296 11.268
202103 9.773 108.360 11.924
202106 9.760 108.928 11.846
202109 10.023 110.338 12.009
202112 9.997 112.486 11.750
202203 10.013 114.825 11.529
202206 10.178 118.384 11.366
202209 10.248 122.296 11.078
202212 10.627 126.365 11.118
202303 10.735 127.042 11.171
202306 10.571 129.407 10.800
202309 10.509 130.224 10.669
202312 10.797 131.912 10.821
202403 11.410 132.205 11.410

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Getinge AB  (OTCPK:GNGBF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Getinge AB Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Getinge AB's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Getinge AB (Getinge AB) Business Description

Address
Lindholmspiren 7A, P.O. Box 8861, Gothenburg, SWE, SE-417 56
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (54% of revenue), surgical workflows (32%), and life sciences (14%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%.